EARLY RESPONSE AND GENETICS DEFINE RELAPSE RISK AFTER FRONTLINE BLINATUMOMAB IN CHILDHOOD B-ALL: A COHORT STUDY.

Vieira Martins M, Enshaei A, Wang YY, Gibson J, Hancock JP, Adams SP, Hodder A, Spence A, Malone A, King A, Castleton A, Mitchell BR, Dalley C, Rowntree C, Ingham D, Devenney D, Bonney DK, Nicholson EK, Jigoulina G, Elbeshlawi I, Motwani J, Bhuller K, Patrick K, Clesham K, Hodby K, Lindsay K, George LC, Madni M, Gattens M, Connor P, Tewari S, Ramanathan S, Baird S, O'Connor D, Hough RE, Moppett J, Vora A, Moorman AV, Samarasinghe S

Open source

DOI: 10.1182/bloodadvances.2026021026
Published: 2026 Sep 1
Container: Blood advances
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2026021026,
  title = {EARLY RESPONSE AND GENETICS DEFINE RELAPSE RISK AFTER FRONTLINE BLINATUMOMAB IN CHILDHOOD B-ALL: A COHORT STUDY.},
  author = {Vieira Martins M and Enshaei A and Wang YY and Gibson J and Hancock JP and Adams SP and Hodder A and Spence A and Malone A and King A and Castleton A and Mitchell BR and Dalley C and Rowntree C and Ingham D and Devenney D and Bonney DK and Nicholson EK and Jigoulina G and Elbeshlawi I and Motwani J and Bhuller K and Patrick K and Clesham K and Hodby K and Lindsay K and George LC and Madni M and Gattens M and Connor P and Tewari S and Ramanathan S and Baird S and O'Connor D and Hough RE and Moppett J and Vora A and Moorman AV and Samarasinghe S},
  year = {2026},
  journal = {Blood advances},
  doi = {10.1182/bloodadvances.2026021026},
  url = {https://doi.org/10.1182/bloodadvances.2026021026}
}

RIS

TY  - JOUR
TI  - EARLY RESPONSE AND GENETICS DEFINE RELAPSE RISK AFTER FRONTLINE BLINATUMOMAB IN CHILDHOOD B-ALL: A COHORT STUDY.
AU  - Vieira Martins M
AU  - Enshaei A
AU  - Wang YY
AU  - Gibson J
AU  - Hancock JP
AU  - Adams SP
AU  - Hodder A
AU  - Spence A
AU  - Malone A
AU  - King A
AU  - Castleton A
AU  - Mitchell BR
AU  - Dalley C
AU  - Rowntree C
AU  - Ingham D
AU  - Devenney D
AU  - Bonney DK
AU  - Nicholson EK
AU  - Jigoulina G
AU  - Elbeshlawi I
AU  - Motwani J
AU  - Bhuller K
AU  - Patrick K
AU  - Clesham K
AU  - Hodby K
AU  - Lindsay K
AU  - George LC
AU  - Madni M
AU  - Gattens M
AU  - Connor P
AU  - Tewari S
AU  - Ramanathan S
AU  - Baird S
AU  - O'Connor D
AU  - Hough RE
AU  - Moppett J
AU  - Vora A
AU  - Moorman AV
AU  - Samarasinghe S
PY  - 2026
JO  - Blood advances
DO  - 10.1182/bloodadvances.2026021026
UR  - https://doi.org/10.1182/bloodadvances.2026021026
ER  -

APA

M, V. M., A, E., YY, W., J, G., JP, H., SP, A., A, H., A, S., A, M., A, K., A, C., BR, M., C, D., C, R., D, I., D, D., DK, B., EK, N., G, J., I, E., J, M., K, B., K, P., K, C., K, H., K, L., LC, G., M, M., M, G., P, C., S, T., S, R., S, B., D, O., RE, H., J, M., A, V., AV, M., & S, S. (2026). EARLY RESPONSE AND GENETICS DEFINE RELAPSE RISK AFTER FRONTLINE BLINATUMOMAB IN CHILDHOOD B-ALL: A COHORT STUDY.. Blood advances. https://doi.org/10.1182/bloodadvances.2026021026

Source records

pubmed · retrieved 2026-09-26T09:06:22.045Z